Coronavirus Drug Discovery: Volume 2: Antiviral Agents from Natural Products and Nanotechnological Applications

Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications is a comprehensive resource for drug developers, medicinal chemists, pharmaceutical companies, and research institutes looking to develop treatments for COVID-19. It provides detailed information on antiviral agents from natural products and nanotechnology applications for efficient and effective drug delivery.

Format: Paperback / softback
Length: 382 pages
Publication date: 01 July 2022
Publisher: Elsevier - Health Sciences Division

Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications is a comprehensive resource that delves into the realm of drug discovery against the novel coronavirus (COVID-19). This volume encompasses a wide range of topics, providing detailed insights into the various antiviral agents derived from natural products that hold potential as chemical scaffolds for developing effective treatments against COVID-19. Additionally, it explores the dietary sources of antioxidant bioactives that can bolster the immune system and aid in managing the symptoms of COVID-19. Furthermore, the book showcases the application of nanotechnology in delivering drugs against COVID-19, offering efficient and targeted approaches to combat the pandemic.

Written by a distinguished global team of experts, this book serves as an invaluable resource for drug developers, medicinal chemists, pharmaceutical companies engaged in research and development, as well as research institutes in both academia and industry. It offers a comprehensive and up-to-date examination of the latest developments in coronavirus drug discovery, providing valuable guidance and insights for those engaged in the fight against this global health crisis.

The first section of the book focuses on the exploration of antiviral agents derived from natural products. These agents, which are derived from plants, microorganisms, or other natural sources, have shown promising potential in the fight against COVID-19. Chapters in this section provide detailed information on the chemical structures, biological activities, and potential therapeutic applications of these natural products as antiviral agents.

One notable aspect of this section is the emphasis on using natural products as chemical scaffolds for developing drugs against COVID-19. By understanding the structural features and biological activities of these natural products, researchers can design and synthesize novel compounds that mimic their effects and enhance their potency. This approach not only offers a more sustainable and environmentally friendly approach to drug discovery but also has the potential to reduce the development time and costs associated with traditional drug development processes.

Another important topic covered in this section is the identification of dietary sources of antioxidant bioactives that can boost the immune system and aid in managing COVID-19. Antioxidants are known to play a crucial role in protecting cells from oxidative stress, which can exacerbate the symptoms of COVID-19. By consuming a diet rich in antioxidant-rich foods, individuals can support their immune system and improve their overall health status, which may in turn reduce the risk of developing severe complications of COVID-19.

The second section of the book explores the application of nanotechnology in delivering drugs against COVID-19. Nanotechnology refers to the use of nanoparticles, which are tiny particles with unique properties, to enhance the effectiveness and delivery of drugs. Chapters in this section discuss the use of nanotechnology in developing drug delivery systems, such as nanoparticles, liposomes, and gene therapy vectors, that can target COVID-19 cells and improve the efficacy of drug treatments.

One of the key advantages of nanotechnology in drug delivery is its ability to target specific cells and tissues. Nanoparticles can be designed to bind to specific proteins or receptors on the surface of COVID-19 cells, making them more susceptible to drug treatment. This targeted approach can reduce the side effects of drug treatments and improve the overall effectiveness of treatment, particularly for patients with severe COVID-19 symptoms.

In addition to drug delivery, nanotechnology is also being used in the development of diagnostic tools and vaccines for COVID-19. Nanoparticles can be used to enhance the sensitivity and specificity of diagnostic tests, making it easier and faster to detect COVID-19 infections. Nanoparticles can also be used as vaccine carriers, delivering antigens to the immune system and stimulating an immune response against COVID-19.

Overall, Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications is a comprehensive and timely resource that provides valuable insights into the ongoing efforts to combat COVID-19. By exploring the potential of natural products, nanotechnology, and dietary sources of antioxidant bioactives, this book offers a multidisciplinary approach to drug discovery and provides a roadmap for developing effective treatments and interventions against this global health crisis.

Weight: 450g
Dimension: 229 x 152 (mm)
ISBN-13: 9780323955744